CLINICAL_TRIALS
trial_result
· 2021-07-13
Clinical Trial Update: Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. [Phase 3]
Summary
Phase 3 trial update reporting efficacy and safety of SPD465 in adults with moderately symptomatic ADHD.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED